[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.166.5.76. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Citations 0
Letters
February 2, 2000

Glycosylated Hemoglobin as a Diagnostic Test for Type 2 Diabetes Mellitus

Author Affiliations
 

Phil B.FontanarosaMD, Deputy EditorIndividualAuthorStephen J.LurieMD, PhD, Fishbein FellowIndividualAuthor

JAMA. 2000;283(5):605-607. doi:10.1001/jama.283.5.601

To the Editor: The article by Dr Davidson and colleagues1 and the Editorial by Dr Vinicor2 bring attention to the increasing importance of the glycosylated hemoglobin (HbA1C) in the diagnosis and therapy of glucose intolerance and of diabetes mellitus. To simplify the complex approach of Davidson et al, one may say that HbA1C, which is a surrogate test for glycosylation of proteins throughout the body, should be the arbitrator test when a high-sensitivity screening test with a known false-positive rate is used. Vinicor takes a more conservative approach because not all complications of diabetes can be associated with HbA1C results.

First Page Preview View Large
First page PDF preview
First page PDF preview
×